<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="2340">
<titleInfo>
<title>Asian Journal of Pharmaceutical Sciences Volume 19, Issue 6 2024</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text">China</placeTerm></place>
<publisher>China Medical University</publisher>
<dateIssued>2024</dateIssued>
<issuance>monographic</issuance>
<edition>Volume 19, Issue 6 2024</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Jurnal</form>
<extent></extent>
</physicalDescription>
<note>a b s t r a c t
Ischemia/reperfusion (I/R) injury is marked by the restriction and subsequent restoration of
blood supply to an organ. This process can exacerbate the initial tissue damage, leading to
further disorders, disability, and even death. Extracellular vesicles (EVs) are crucial in cell
communication by releasing cargo that regulates the physiological state of recipient cells.
The development of EVs presents a novel avenue for delivering therapeutic agents in I/R
therapy. The therapeutic potential of EVs derived from stem cells, endothelial cells, and
plasma in I/R injury has been actively investigated. Therefore, this review aims to provide
an overview of the pathological process of I/R injury and the biophysical properties of EVs.
We noted that EVs serve as nontoxic, flexible, and multifunctional carriers for delivering
therapeutic agents capable of intervening in I/R injury progression. The therapeutic efficacy
of EVs can be enhanced through various engineering strategies. Improving the tropism of
EVs via surface modification and modulating their contents via preconditioning are widely
investigated in preclinical studies. Finally, we summarize the challenges in the production
and delivery of EV-based therapy in I/R injury and discuss how it can advance. This review
will encourage further exploration in developing efficient EV-based delivery systems for I/R treatment.</note>
<subject authority=""><topic>Ischemia/reperfusion injury</topic></subject>
<subject authority=""><topic>Extracellular vesicle engineering</topic></subject>
<subject authority=""><topic>Extracellular vesicles</topic></subject>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0123</numerationAndChronology>
<sublocation>Perpus.Akfarsam (Jurnal Farmasi Internasional)</sublocation>
<shelfLocator>615 ASI</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="2212" url="https://drive.google.com/file/d/11vWJRfqAMMeYnXRvkAMP7qv7eNqWtd71/view?usp=sharing" path="/https://drive.google.com/file/d/11vWJRfqAMMeYnXRvkAMP7qv7eNqWtd71/view?usp=sharing" mimetype="text/uri-list">Volume 19, Issue 6 2024</slims:digital_item>
</slims:digitals><slims:image>Volume_19%2C_Issue_6.jpeg.jpeg</slims:image>
<recordInfo>
<recordIdentifier>2340</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2026-07-10 09:47:11</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2026-07-10 09:50:01</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>